ahlam1399
08-08-2016, 07:51 PM
UPDATE 2-Allergan revenue disappoints as Alzheimer drug loses exclusivity
Aug 8 (Reuters) – Allergan Plc reported
weaker-than-expected quarterly revenue after sales of its
Alzheimer’s drug, Namenda IR, collapsed following the loss of
patent exclusivity, and the company cut…http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=4bI4OwojQ-A:2Cv4Zj1CU9c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=4bI4OwojQ-A:2Cv4Zj1CU9c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=4bI4OwojQ-A:2Cv4Zj1CU9c:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=4bI4OwojQ-A:2Cv4Zj1CU9c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=4bI4OwojQ-A:2Cv4Zj1CU9c:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/4bI4OwojQ-A
Aug 8 (Reuters) – Allergan Plc reported
weaker-than-expected quarterly revenue after sales of its
Alzheimer’s drug, Namenda IR, collapsed following the loss of
patent exclusivity, and the company cut…http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=4bI4OwojQ-A:2Cv4Zj1CU9c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=4bI4OwojQ-A:2Cv4Zj1CU9c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=4bI4OwojQ-A:2Cv4Zj1CU9c:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=4bI4OwojQ-A:2Cv4Zj1CU9c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=4bI4OwojQ-A:2Cv4Zj1CU9c:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/4bI4OwojQ-A